Home » Topics » Conferences

Conferences
RSS

Second-generation, highly selective COX-2 inhibitors developed at Merck

Nov. 18, 1997

SomatoKine shows potential for the treatment of osteoporosis

Nov. 18, 1997

Safety, immunogenicity and efficacy of anti-TNF antibody in RA patients

Nov. 18, 1997

Data presented on Shionogi's S-2150

Nov. 18, 1997

COX-2 antisense therapy for rheumatoid arthritis

Nov. 18, 1997

Improvement in early and established arthritis with antiangiogenic therapy

Nov. 18, 1997

Pharmacokinetic profile of ciclosporin derivative IMM-125

Nov. 18, 1997

Dainippon develops sustained-release morphine preparation

Nov. 18, 1997

Pharmacokinetic profile of Taisho's ACAT inhibitor

Nov. 18, 1997

New cardiotonic candidate studied, rejected at Fujisawa

Nov. 18, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...